Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Concomitant Administration of Ozanimod and Serotonergic Antidepressants in Patients With Ulcerative Colitis or Relapsing Multiple Sclerosis.
Journal: Inflammatory bowel diseases
Published: February 16, 2024
Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn's Disease, and Relapsing Multiple Sclerosis.
Journal: Inflammatory bowel diseases
Published: October 27, 2023
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension.
Journal: Journal of Crohn's & colitis
Published: August 31, 2023
Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension Analyses.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: August 03, 2023
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Journal: The New England journal of medicine
Published: September 29, 2021
Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study.
Journal: Journal of Crohn's & colitis
Published: January 13, 2021
Long-term Safety of Sunitinib in Metastatic Renal Cell Carcinoma.
Journal: European urology
Published: March 01, 2015
Showing 1-7 of 7
Last Updated: 09/26/2026